Venrock Partners, L.P. is 10% Owner at Bellerophon Therapeutics, Inc. (BLPH). They have made 4 open-market trades across 3 companies since 2006, most recently 2018-09-17.
CIK 0001305239
4 open-market purchases totalling $3.9M since 2006, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.